SERNOVA CORP. news, videos and press releases
For more news please use our advanced search feature.
SERNOVA CORP. - More news...
SERNOVA CORP. - More news...
- Sernova Biotherapeutics Secures $4 Million Loan to Further Advance its Clinical Development Plans
- Sernova Biotherapeutics Cell Pouch Bio-hybrid Organ to be Highlighted at Cell & Gene Meeting on the Med
- Sernova Biotherapeutics Provides Update on Phase 1/2 Clinical Trial of Cell Pouch™ Bio-Hybrid Organ for Treatment of Type 1 Diabetes
- Sernova Biotherapeutics Appoints Pericles Calias, Ph.D. as Chief Development Officer and Head of R&D
- Sernova Biotherapeutics Secures $1 Million Convertible Debt Financing
- Sernova Biotherapeutics Receives FDA Clearance for IND Application for its Cell Pouch Bio-hybrid Organ with Autograft Thyroid Cells in Patients with Hypothyroidism
- Sernova Biotherapeutics Submits IND Application for its Cell Pouch Bio-Hybrid Organ with Autograft Thyroid Cells in Patients with Hypothyroidism
- Sernova Announces Appointment of Ross Haghighat as Chair of the Board and a Change of Name to Sernova Biotherapeutics
- Sernova Announces Voting Results from its Annual and Special General Meeting of Shareholders
- Sernova Reschedules its Annual General and Special Meeting of Shareholders to January 10, 2025
- Sernova Update on Strategic Initiatives
- Sernova Announces New Positive Data from Phase I/II Trial Regarding Islet Survival and Function
- Sernova Corp. Announces Appointment of New Chief Executive Officer
- Sernova Receives Orphan Drug and Rare Pediatric Disease Designations for its Hemophilia A Program from FDA
- Sernova Announces New Advancements of Conformal Coating Technology in Combination with the Cell Pouch System™ at the 2023 IPITA-IXA-CTRMS Joint Congress
- Sernova Announces Positive Ongoing Interim Phase 1/2 Clinical Data for the Cell Pouch System™ for Type 1 Diabetes Trial at the 2023 IPITA, IXA, and CTRMS Joint Congress
- Sernova to Provide Two Program Updates in Podium Presentations at 2023 IPITA Congress
- Sernova Presents Compelling New Data on the Cell Pouch System™ as a Promising Treatment for Post-Operative Hypothyroidism at the 2023 American Thyroid Association Annual Meeting
- EQS-News: Sernova Investor Conference Call Previously Scheduled for September 15 Now Rescheduled for September 22
- Sernova Investor Conference Call Previously Scheduled for September 15 Now Rescheduled for September 22
- EQS-News: Sernova to Host Investor Calls to Introduce Newly Appointed CEO and Provide Business Update
- Sernova to Host Investor Calls to Introduce Newly Appointed CEO and Provide Business Update
- Sernova Provides Development Update on Proprietary Cellular Conformal Coating Technology in Combination with Cell Pouch Device
- Sernova Corporation Announces the Appointment of Cynthia Pussinen as CEO
- Sernova Expands Leadership Team with Appointment of Modestus Obochi, Ph.D., MBA, as Chief Business Officer
- Sernova Announces Positive Updated Interim Phase 1/2 Clinical Data for the Cell Pouch System™ at American Diabetes Association 83rd Scientific Sessions
- Sernova to Present Updated Interim Phase 1/2 Clinical Data on Cell Pouch System™ During Oral Presentation at American Diabetes Association 83rd Scientific Sessions
- Sernova to Participate in Upcoming Truist Securities Cell Therapy Symposium
- Sernova Announces Executive Alignment and Appoints New Board Chair
- EQS-News: Sernova Announces Research Collaboration with AstraZeneca to Evaluate Novel Potential Therapeutic Cell Applications
